Insulet Corporation PODD
Insulet Corporation, operating under the brand Omnipod, is a medical device company that develops, manufactures, and markets innovative insulin delivery systems for people with diabetes. The company's primary product is the Omnipod Insulin Management System, a tubeless, wearable insulin pump that provides continuous subcutaneous insulin infusion. This system includes a disposable Pod that adheres to the skin and a handheld Personal Diabetes Manager (PDM) or smartphone app for wireless control and monitoring. Insulet serves a global customer base, including patients in the United States and numerous international markets such as Canada, the United Kingdom, Germany, France, and several countries in the Middle East and Asia. Its business model revolves around the sale of its proprietary Pods, which are disposable and generate recurring revenue, while the handheld controllers are often provided at a low cost or as part of a system to drive Pod adoption. The company focuses on making diabetes management simpler and more discreet for patients, reducing the burden of daily injections and traditional tubed pumps.
LSTM Forecast
Forecast model is not trained yet for this market.
Train and backfill the LSTM forecast to surface a directional view here.